Combinatorial |
Panel- or pattern-based |
Diagnostic |
Disease-specific |
Differentiation |
Efficacy or safety of drugs within same class |
Efficacy |
Reflects positive outcome of a treatment |
Exploratory |
Delimited, may be driven by discovery, not hypothesis |
Pharmacodynamic |
Contrasting pharmacodynamic patterns may offer utility for treatment (optimal dose?) |
Prognostic |
Predict course of disease |
Predictive |
Provides information on obtaining response to treatment (optimal drug?) |
Qualified |
The data support its use for stated purpose |
Risk |
Can be used for risk stratification |
Toxicity |
Avoid/monitor potential toxic effects |
Screening |
Early disease detection |
Staging |
Differentiates different stages, activity, and subtypes of disease |
Stand-alone |
A single biomarker sufficient for purpose by itself |
Stratification |
Select best treatment for given patient |
Surrogate |
Intended as substitute for clinical endpoint |
Translational |
Can be used in pre-clinical and clinical studies |